Physician profile
Paul E Tocci
NPI 1699856211
$2,593.37
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $909 · 2020: $414 · 2021: $613 · 2022: $457 · 2023: $200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $199.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $467.92 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $459.67 | 2019-2022 | |
| Janssen Biotech, INC. | $322.64 | 2019-2023 | Erleada |
| Myriad Genetic Laboratories, INC. | $289.34 | 2021-2023 | Myrisk |
| Tolmar Pharmaceuticals, INC. | $220.92 | 2019-2022 | |
| Boston Scientific Corporation | $113.09 | 2019-2023 | Rezum Generator |
| Olympus America INC. | $106.84 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $90.15 | 2022-2023 | |
| Pfizer INC. | $82.61 | 2019-2022 | |
| Coloplast Corp | $78.01 | 2019-2022 | |
| Ferring Pharmaceuticals INC. | $66.93 | 2019 | |
| Dentsply Ih INC. | $52.47 | 2019-2020 | |
| Myovant Sciences INC. | $51.48 | 2021 | |
| Teleflex LLC | $40.48 | 2021 | |
| Convatec INC. | $33.77 | 2019-2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acerus Pharmaceuticals Corporation | $23.78 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $22.55 | 2022 | |
| Antares Pharma, INC. | $20.42 | 2023 | Nocdurna, Xyosted, Tlando |
| Blue Earth Diagnostics | $18.95 | 2022 | |
| Clarus Therapeutics INC. | $17.66 | 2021 | |
| Rgh Enterprises LLC | $13.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Tocci listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.